Argenx Se (ARGX) Enterprise Value (2015 - 2025)
Argenx Se (ARGX) posted Enterprise Value of -$4.4 billion for Q4 2025, up 99.76% on a QoQ basis from -$1842.2 billion in Q2 2025, and down 31.41% year-over-year from -$6.5 billion in Q4 2024.
Argenx Se (ARGX) Enterprise Value (2015 - 2025) Analysis & Trends
Argenx Se's Enterprise Value history runs 11 years deep, the most recent figure standing at -$4.4 billion for Q4 2025.
- Quarterly Enterprise Value fell 31.41% year-over-year to -$4.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.4 billion (down 31.41% YoY) and the FY2025 annual result came in at -$5.9 billion, down 960.11% from the prior year.
- Enterprise Value was -$4.4 billion for Q4 2025 at Argenx Se, up from -$1842.2 billion in the prior quarter.
- Across five years, Enterprise Value topped out at $1107.0 billion in Q2 2024 and bottomed at -$1842.2 billion in Q2 2025.
- A 5-year average of -$75.8 billion and a median of -$2.7 billion in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 55532.62% — and 2025, when it tumbled 266.42%.
- Argenx Se's Enterprise Value stood at -$2.3 billion in 2021, then gained by 6.17% to -$2.2 billion in 2022, then plunged by 45.03% to -$3.2 billion in 2023, then decreased by 6.26% to -$3.4 billion in 2024, then sank by 31.41% to -$4.4 billion in 2025.
- Business Quant data shows ARGX's Enterprise Value at -$4.4 billion in Q4 2025, -$1842.2 billion in Q2 2025, and -$3.4 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | -3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.44 Bn |
| Jun 30, 2025 | -1,842.20 Bn |
| Dec 31, 2024 | -3.38 Bn |
| Jun 30, 2024 | 1,106.97 Bn |
| Dec 31, 2023 | -3.18 Bn |
| Jun 30, 2023 | -2.00 Bn |
| Dec 31, 2022 | -2.19 Bn |
| Jun 30, 2022 | -2.60 Bn |
| Dec 31, 2021 | -2.34 Bn |
| Jun 30, 2021 | -2.73 Bn |
| Dec 31, 2020 | -1.94 Bn |
| Jun 30, 2020 | -2.13 Bn |
| Dec 31, 2019 | -1.48 Bn |
| Jun 30, 2019 | -1.06 Bn |
| Dec 31, 2018 | -644.40 Mn |
| Jun 30, 2018 | -404.40 Mn |
| Dec 31, 2017 | -423.61 Mn |
| Jun 30, 2017 | -190.69 Mn |
| Dec 31, 2016 | -104.44 Mn |
| Dec 31, 2015 | -46.40 Mn |